ERC Starting Grant · 2023
Hyperpolarized Magnetic Resonance at the point-of-care
HYPMET proposes a pioneering research methodology for hyperpolarized magnetic resonance for real-time monitoring of upregulated metabolic pathways in cancer cells and in-vivo and for body fluid metabolic analyses with the prospect of revolutionizing the medical approach to personalised treatments. A common analytical method for structural biology, medical imaging, and chemical analysis is nuclear magnetic resonance (NMR), which is flexible but intrinsically insensitive. Even in the most sensitive NMR spectra, many endogenous compounds found in blood, saliva, or urine are currently unresolved. HYPMET will establish a ground-breaking technology enabling the detection of body fluids…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.